Export 36 results:
Author [ Keyword] Title Year Filters: Author is Palsson, Olafur S [Clear All Filters]
Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.. Am J Gastroenterol. 105(10):2228-34.
.
2010. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.. Am J Gastroenterol. 105(10):2228-34.
.
2010. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.. Am J Gastroenterol. 105(10):2228-34.
.
2010. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.. Am J Gastroenterol. 105(10):2228-34.
.
2010. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.. Am J Gastroenterol. 105(10):2228-34.
.
2010. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.. Am J Gastroenterol. 105(10):2228-34.
.
2010. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.. Am J Gastroenterol. 105(10):2228-34.
.
2010. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.. Am J Gastroenterol. 105(10):2228-34.
.
2010. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.. Am J Gastroenterol. 105(10):2228-34.
.
2010. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.. BMC Complement Altern Med. 8:46.
.
2008. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.. Am J Gastroenterol. 105(10):2228-34.
.
2010.